Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05960929
PHASE3

InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS

Sponsor: ONY

View on ClinicalTrials.gov

Summary

The purpose of this clinical study is to determine the effectiveness and safety of Infasurf® administered through the InfasurfAero™, a novel oral airway delivery device specifically designed to give Infasurf in a less complicated way and without the need for a breathing tube or interrupting nasal respiratory support.

Official title: InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS: A Single-dose, Double-blind, Random Allocation, Sham-control, Clinical Trial

Key Details

Gender

All

Age Range

29 Weeks - 36 Weeks

Study Type

INTERVENTIONAL

Enrollment

220

Start Date

2025-01-01

Completion Date

2026-04-01

Last Updated

2025-03-30

Healthy Volunteers

No

Interventions

COMBINATION_PRODUCT

Infasurf Aero™

A single dose of Calfactant administered by pacifier interface by inhalation via the Infasurf Aero nebulizer at 6ml/kg.

Locations (10)

St. Josephs Hospital and Medical Center

Phoenix, Arizona, United States

Phoenix Children's

Phoenix, Arizona, United States

Sharp Mary Birch Hospital for Women & Newborns

San Diego, California, United States

University of Florida -Jacksonville

Jacksonville, Florida, United States

Kapi'olani Medical Center for Women & Children

Honolulu, Hawaii, United States

Jersey Shore University Medical Center

Neptune City, New Jersey, United States

Sisters of Charity Hospital

Buffalo, New York, United States

Western TN- Jackson-Madison County General Hospital

Jackson, Tennessee, United States

Utah Valley Hospital

Provo, Utah, United States

Unity Point Meriter

Madison, Wisconsin, United States